» Articles » PMID: 2988728

The Contribution of Exoproducts to Virulence of Pseudomonas Aeruginosa

Overview
Journal Can J Microbiol
Specialty Microbiology
Date 1985 Apr 1
PMID 2988728
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa produces a large number of extracellular products which may contribute to its virulence. We have employed a genetic approach to determine the contribution of toxin A, exoenzyme S, elastase and alkaline protease to the pathogenesis of P. aeruginosa. Mutations have been introduced with chemicals or transposons. Mutants have been identified using immunological, chemical, or toxicity assays. Mutants were extensively characterized in vitro to ascertain that they were identical to their parent strain except for the production of the desired product. Appropriate mutants were compared with their parent strains in several animal models: the burned mouse model, the mouse corneal infection model, and a rat model of chronic lung infection. The data indicate that virulence of P. aeruginosa is multifactorial. Further, the relative contribution of a given P. aeruginosa product may vary with the type of infection.

Citing Articles

Evolution and regulation of microbial secondary metabolism.

Santamaria G, Liao C, Lindberg C, Chen Y, Wang Z, Rhee K Elife. 2022; 11.

PMID: 36409069 PMC: 9708071. DOI: 10.7554/eLife.76119.


Exploiting RNA thermometer-driven molecular bioprocess control as a concept for heterologous rhamnolipid production.

Noll P, Treinen C, Muller S, Lilge L, Hausmann R, Henkel M Sci Rep. 2021; 11(1):14802.

PMID: 34285304 PMC: 8292423. DOI: 10.1038/s41598-021-94400-4.


A Primed Subpopulation of Bacteria Enables Rapid Expression of the Type 3 Secretion System in Pseudomonas aeruginosa.

Lin C, Lee D, McKeithen-Mead S, Emonet T, Kazmierczak B mBio. 2021; 12(3):e0083121.

PMID: 34154400 PMC: 8262847. DOI: 10.1128/mBio.00831-21.


High pyocyanin production and non-motility of Pseudomonas aeruginosa isolates are correlated with septic shock or death in bacteremic patients.

Gupte A, Jyot J, Ravi M, Ramphal R PLoS One. 2021; 16(6):e0253259.

PMID: 34115807 PMC: 8195364. DOI: 10.1371/journal.pone.0253259.


Keratitis: Protease IV and PASP as Corneal Virulence Mediators.

OCallaghan R, Caballero A, Tang A, Bierdeman M Microorganisms. 2019; 7(9).

PMID: 31443433 PMC: 6780138. DOI: 10.3390/microorganisms7090281.